Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportHead and Neck

PET/MRI Radiomics Analysis in Predicting the Ascending and Descending Nasopharyngeal Carcinoma

Jiangtao Liang
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 3099;
Jiangtao Liang
1Hangzhou Universal Imaging Diagnostic Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

3099

Introduction: To evaluate the value of PET/MRI radiomics model in predicting the ascending and descending types of nasopharyngeal carcinoma (NPC).

Methods: From June 2017 to October 2021, the clinical data and PET/MR imaging data of 327 NPC patients (72 ascending type and 255 descending type) with undifferentiated carcinoma from a medical center were collected. The patients were randomly divided into training group (n=229) and verification group (n=98). We measured the metabolic parameters (SUVmax, MTV, TLG) of the NPC primary focus with GE post-processing workstation, and used AK software to extract the most relevant radiomics features to NPC types, then constructed the corresponding radiomics signature. Multivariable logistic regression analysis was performed with radiomics signature and clinical variables for developing the prediction model. The receiver operating characteristic(ROC) analysis was used to evaluate the prediction model.

Results: Eight features were selected by the LASSO from 2600 radiomics features. The established radiomics signature has better prediction efficiency for identifying the ascending and descending NPC. The AUCs were 0.899 (95% CI: 0.847 - 0.996) and 0.886 (95% CI: 0.735 – 1.000) in the training group and the verification group, respectively. On multivariable logistic regression, the radiomics signature and total lesion glycolysis (TLG) were considered to be independent and significant risk factors for NPC type (The ascending type vs. The descending type) of NPC. The combined prediction model showed good discrimination in both training group (AUC=0.954, 95%CI:0.801 to 0.998; sensitivity=0.935, specificity=0.734, positive predictive value=0.998, negative predictive value=0.890) and verification group (AUC=0.968, 95% CI: 0.856 to 0.998, sensitivity=0.925, specificity=1.000, positive predictive value=0.913, negative predictive value=0.900).

Conclusions: The radiomics predictive model which integrated with the radiomics signature and metabolic parameters (TLG) can be used as a promising and applicable adjunct approach for predicting the ascending and descending NPC.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET/MRI Radiomics Analysis in Predicting the Ascending and Descending Nasopharyngeal Carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET/MRI Radiomics Analysis in Predicting the Ascending and Descending Nasopharyngeal Carcinoma
Jiangtao Liang
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 3099;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET/MRI Radiomics Analysis in Predicting the Ascending and Descending Nasopharyngeal Carcinoma
Jiangtao Liang
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 3099;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Diagnostic Performance of 18F Fibroblast Activation Protein Inhibitor (FAPI)-42 PET Compared with Multiparametric MRI for Glioma Grading
  • The Role of 18F-PSMA-1007 PET-CT Imaging In Treatment Management Of Malignant Brain Tumors: Pilot Study From Azerbaijan
  • In vivo assessment of CXCR4 receptor expression in High-grade Glioma using [68 Ga] Ga-Pentixafor PET/CT
Show more Head and Neck

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire